"Clostridium Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infections with bacteria of the genus CLOSTRIDIUM.
| Descriptor ID |
D003015
|
| MeSH Number(s) |
C01.252.410.222
|
| Concept/Terms |
Clostridium Infections- Clostridium Infections
- Infections, Clostridium
- Clostridium Infection
- Infection, Clostridium
Clostridium difficile Infection- Clostridium difficile Infection
- Clostridium difficile Infections
- Infection, Clostridium difficile
- Infections, Clostridium difficile
Clostridium sordellii Infection- Clostridium sordellii Infection
- Clostridium sordellii Infections
- Infection, Clostridium sordellii
- Infections, Clostridium sordellii
Clostridium perfringens Infections- Clostridium perfringens Infections
- Clostridium perfringens Infection
- Infection, Clostridium perfringens
- Infections, Clostridium perfringens
|
Below are MeSH descriptors whose meaning is more general than "Clostridium Infections".
Below are MeSH descriptors whose meaning is more specific than "Clostridium Infections".
This graph shows the total number of publications written about "Clostridium Infections" by people in this website by year, and whether "Clostridium Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 2 | 0 | 2 |
| 2016 | 1 | 1 | 2 |
| 2017 | 3 | 0 | 3 |
| 2018 | 2 | 0 | 2 |
| 2019 | 5 | 1 | 6 |
| 2020 | 4 | 0 | 4 |
| 2021 | 3 | 0 | 3 |
| 2022 | 2 | 0 | 2 |
| 2023 | 2 | 0 | 2 |
| 2024 | 3 | 1 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Clostridium Infections" by people in Profiles.
-
A quantitative PCR to detect non-toxigenic Clostridioides difficile. Microbiol Spectr. 2025 Jan 07; 13(1):e0160824.
-
Antibacterial activity of ibezapolstat against antimicrobial-resistant clinical strains of Clostridioides difficile. Antimicrob Agents Chemother. 2024 03 06; 68(3):e0162123.
-
Microscopy methods for Clostridioides difficile. Anaerobe. 2024 Apr; 86:102822.
-
Fecal Pharmacokinetics and Gut Microbiome Effects of Oral Omadacycline Versus Vancomycin in Healthy Volunteers. J Infect Dis. 2024 01 12; 229(1):273-281.
-
The Novel DNA Binding Mechanism of Ridinilazole, a Precision Clostridiodes difficile Antibiotic. Antimicrob Agents Chemother. 2023 05 17; 67(5):e0156322.
-
Nonmammalian models to study Clostridioides difficile infection; a systematic review. Anaerobe. 2023 Feb; 79:102694.
-
Efficacy, Safety, Pharmacokinetics, and Microbiome Changes of Ibezapolstat in Adults with Clostridioides difficile Infection: A Phase 2a Multicenter Clinical Trial. Clin Infect Dis. 2022 09 30; 75(7):1164-1170.
-
Multi-country surveillance of Clostridioides difficile demonstrates high prevalence of spores in non-healthcare environmental settings. Anaerobe. 2022 Jun; 75:102543.
-
Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains. Anaerobe. 2021 Dec; 72:102440.
-
Systems biology evaluation of refractory Clostridioides difficile infection including multiple failures of fecal microbiota transplantation. Anaerobe. 2021 Aug; 70:102387.